SCP
TARO

Seizert Capital Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Seizert Capital Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-34,483
Closed -$3.4M – 251
2018
Q2 		$3.4M Hold
34,483
– – 0.12% 75
2018
Q1 		$3.4M Buy
34,483
+18,295
+113% +$1.85M 0.12% 75
2017
Q4 		$1.7M Buy
+16,188
New +$1.78M 0.06% 121

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Seizert Capital Partners's TARO Position: Q3 2018 in Review

Seizert Capital Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 34,483 shares — an estimated $3.4M sold.

Seizert Capital Partners first reported a position in TARO in Q4 2017 and held it in 3 quarters. The position peaked at $3.4M in Q2 2018. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

  • Seizert Capital Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
  • Seizert Capital Partners sold 34,483 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $3.4M.
  • Seizert Capital Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 3 quarters.
  • Seizert Capital Partners's Taro Pharmaceutical Industries Ltd. position peaked at $3.4M in Q2 2018.
  • 114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Seizert Capital Partners's 13F filing for Q3 2018, filed 9 Nov 2018.